“Tong’s specialized scientific background and analytical approach in an extremely technical industry offers a unique perspective to our network. She leads with a progressive mindset and develops teams and businesses that open doors for future generations,” said Larraine Segil, Chair & CEO of EWA. “We welcome Tong to EWA and look forward to her contributions in our expanding network of women!”
“I’ve had the pleasure of knowing Tong for nearly a decade. Within the molecular diagnostics field, she possesses an exceptional ability to spot technologies ripe for commercialization. With her assistance, Wondfo successfully devised a strategy and acquired multiple platforms. Tong excels as an executive and boardroom presence, actively listening to all ideas before sharing her valuable insights and advice. Her track record demonstrates not only efficient plan execution but also adept guidance for others during challenging times,” said Jian Han, Founder & Chairman, iRepertoire & iCubate.
Dr. Zhang is an expert in commercial IVD molecular diagnostics assay research and development, including obtaining FDA 510K and CE approvals for next-generation sample-to-answer medical devices. Her rich background spans molecular and cell biology, infectious disease, cancer, and cardiovascular disease. Additionally, she is renowned for her proficiency in assay development, covering molecular, immunoassay, cellular, and biochemical assays.
With six years of prior service as a board director and advisor for three different biotech companies, Dr. Zhang currently serves on the board of Hura Imaging, a private biotech company.
The Exceptional Women Alliance (EWA) is an invitation only peer mentorship organization where high-potential, high-level Exceptional Women from across multiple industries are hand-selected and invested in, to grow, learn, share, and succeed. In addition to the achievement of significant success, the criteria for acceptance include character traits that are defining of the EWA Culture – Kindness, the Spirit of Generosity, Transparency, Gratitude and Willingness to Share their Networks. The Foundation is a powerhouse of peer-to-peer mentoring that provides guidance, deep connection, and leadership, propelling each woman to sustainable success – one woman at a time. The year-long program enables each member to be connected as alumnae for life in the ever-expanding EWA global network, as their fellow women leaders continue to move into positions of significance. Learn more at https://www.exceptionalwomenalliance.com/ Follow us on Facebook
“At Oshi, we’ve created a clinically rigorous care model to alleviate suffering from digestive health conditions by offering fast access to proven care and therapies, removing patient burdens, and delivering a superior high-touch patient experience,” said Sam Holliday, CEO of Oshi Health. “Telemedicine is an unprecedented tool to enable value-based care, and Oshi is proud to be recognized for demonstrating its potential to transform American healthcare.”
Digestive conditions negatively impact the well-being of 25% of Americans and incur costs greater than heart disease and diabetes. Oshi Health democratizes access to high-value digestive care proven to improve outcomes and significantly reduce healthcare costs. Oshi provides diagnosis and multidisciplinary care through a hybrid collaborative care model, extending and enhancing in-person care and empowering people to gain lasting control of their symptoms and improve their quality of life.
The winners will be announced at the Grand Finale taking place at HLTH on the Moon Stage on October 9, 2023. Visit Oshi Health in the Digital Medicine Society (DiMe)‘s Virtual-First Care (V1C) Pavilion, where Holliday will also be hosting a series of booth-side chats.
About Oshi Health Oshi Health is a completely redesigned digestive health care experience that transforms access to care, the patient experience, clinical outcomes and healthcare economics. In a high-touch virtual care delivery model, Oshi Health provides diagnosis and integrated care for digestive conditions and empowers people to achieve lasting control of their symptoms. Launched in 2020, Oshi Health works with innovative employers, health insurance partners, health systems and community GI practices to scale access to multidisciplinary care, reduce healthcare costs, and improve the lives of millions of Americans with chronic gastrointestinal diseases. For more information, visit http://www.oshihealth.com.
About Digital Health Hub Foundation
Health Hub SF LLC, doing business as the Digital Health Hub Foundation, is a 501(c)3 non-profit, supported by the healthcare venture capital community and others, whose mission is to help the world’s next best innovative healthcare companies scale and grow.
Founded in 2017, on the campus of UCSF in San Francisco, our 30,000 member community consists of thousands of early-to-late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.
Media Contact
Stephanie Hicks, Cosmo Public Relations, Inc for Oshi Health, 805-295-9455, [email protected], Oshi Health
“We’re excited to welcome Dr. Barrett to the Corista leadership team. His background and experience are perfectly positioned to help us better serve digital image management needs of the medical and life sciences markets, creating a more comprehensive solution, and advancing our expansion into new markets,” said Corista CEO Liz Wingard.
“Corista has been a pioneer in developing digital pathology solutions and continues to push its boundaries. I’m enthusiastic about joining a team dedicated to delivering the integration of digital imagery, patient data, biomarkers, and analytics within individual patient files, to accelerate healthcare research and outcomes,” said Dr. Barrett. “My objective is to help Corista bring to market new capabilities that will make our solution an all-encompassing platform for scientists and physicians.”
Prior to joining Corista, Dr. Barrett was Vice President of Translational Medicine and Oncology Biomarker Development in Oncology Research and Development at AstraZeneca Pharmaceuticals. His responsibilities included:
Developing and executing biomarker strategies and translational sciences efforts to support drug development
Backing translational research through early and full development in oncology
Leading a team of experts in genomics, proteomics, computational biology, informatics, computational pathology, and AI
Dr. Barrett also served as the Global Head of Oncology Biomarkers and Imaging at Novartis Oncology Translational Medicine. He was the founding Director of the NCI Center for Cancer Research (CCR), which is part of the NCI Intramural Center for Translational Medicine and Novel Technologies.
Trained as a chemist at the College of William and Mary, Dr. Barrett received his Ph.D. in Biophysical Chemistry from Johns Hopkins University. He has published more than 600 research articles and reviews in leading scientific journals and books.
“Dr. Barrett’s eminent track record speaks volumes. His long-standing research interests have led to several contributions to identifying molecular defects in cancers and the role of the biosystem in the carcinogenesis process. When combining his natural curiosity and interests with what we aim to accomplish in digital pathology, the possibilities are endless,” said Wingard.
Currently, Dr. Barrett is a member of the Johns Hopkins University Society of Scholars, an elected member of the Ramazini Foundation and an honorary member of the Japanese Cancer Association.
About Corista
Corista delivers the industry’s most extensive array of workflow, analytical and collaborative tools for pathology. Medical centers can seamlessly integrate with LIS/EHRs in a unified digital environment of whole-slide, gross and static pathology images. Physicians have 21st-century tools to collaborate, communicate, teach, and report with access to ‘best of breed’ image analytics. Specialists can receive digital consults from remote physicians and patients from across the globe, and investigator-initiated researchers have a research and development platform to develop and apply their algorithms. Corista provides for a new level of interoperability for pathology, integrating whole slide image scanning systems, image analytics, and LIS/EHR platforms with a rich, collaborative environment for physicians, patients, biotech, and pharmaceutical scientists. This is Integrated Pathology™ only from Corista.
New You Plastic Surgery is the practice of board-certified plastic surgeon Dr. Jeremy Nikfarjam. At New You Plastic Surgery in NYC, located at 461 Park Avenue South, 3rd floor, the providers and staff deliver a wide range of cosmetic treatments and plastic surgery procedures to help individuals look their best using cutting-edge surgical techniques for optimal results including Mommy Makeovers, breast implants, facelifts, rhinoplasties, head-to-toe transformations or reconstructive surgeries from an injuries. They pride themselves on providing a comfortable and welcoming experience with personalized care. New You Plastic Surgery provides a range of financing, payment, and insurance options. For more information or to schedule a consultation at the Manhattan location, please visit http://www.thenewyouplasticsurgery.com or call 212-843-9170, and to reach the Englewood, NJ, Poughkeepsie or Roslyn, NY, locations, call 516-279-2616.
“Our work with Amgen over the past six months has been exciting and fruitful. We have enjoyed collaborating with an incredible industry-leading team on this major area of interest,” said David Younger, CEO and Co-Founder of A-Alpha Bio. “We look forward to expanding our collaboration and moving into the validation of glueability and the generation of data to inform rational molecular glue discovery. Combining our technology and expertise with Amgen’s has the potential to generate high-impact therapeutics and advance our mission to improve human health.”
About A-Alpha Bio A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.
The company’s AlphaSeq platform applies synthetic biology to experimentally measure millions of protein-protein interaction affinities simultaneously. Protein binding data is incorporated into the company’s AlphaBind platform to train machine learning models that predict binding from sequence. A-Alpha Bio uses both platforms to discover and optimize high-impact therapeutics for their own pipeline and in partnership with industry leaders.
A-Alpha Bio is based in Seattle and was founded in 2017 at the University of Washington’s Institute for Protein Design and Center for Synthetic Biology. To learn more, please visit: https://www.aalphabio.com/
“We are incredibly proud of our team for becoming an Accredited Geriatric Emergency Department. This accreditation solidifies our ongoing commitment to serve all our patients with the utmost of care,” said Felicia Turnley, CEO, Memorial Hospital Pembroke. “Our team delivers compassionate attention to the specialized care needs of our older population, as outlined by standardized evidence-based clinical practices.”
The GEDA program is the culmination of years of progress in emergency care of older adults. In 2014, ACEP, along with Society for Academic Emergency Medicine, Emergency Nurses Association and American Geriatrics Society, developed and released geriatric ED guidelines, recommending measures ranging from adding geriatric-friendly equipment to specialized staff to more routine screening for delirium, dementia and fall risk, among other vulnerabilities.
To achieve this accreditation, Memorial’s team focused on standardizing approaches to care for commonly seen geriatric concerns.
“We recognize that our older patients who enter the emergency department are out of their home environment, and it’s important for our care teams to be trained in offering them supportive services,” said Dr. Estreicher. “This includes understanding their social environments and supports at home, helping the patients with mobility aids and fall prevention and conducting cognitive screenings for dementia or delirium.”
A priority goal of geriatric accredited emergency departments is to anticipate the medical, social, and emotional needs of older patients and develop innovative care delivery to meet their needs in the hospital and at home. This begins on arrival and continues throughout the emergency visit and discharge, signaling the importance of a rapid and accurate diagnosis, assessment of unmet needs, and identification of specific at-risk indicators. One of the key priorities involves a care team from various specialties who are trained to identify potential risks that trigger interventions to link the patient to crucial services.
The voluntary GEDA program, which includes three levels similar to trauma center designations, provides specific criteria and goals for emergency clinicians and administrators to target. The accreditation process provides more than two dozen best practices for geriatric care. The GEDA Level 3 signifies excellence in older adult care as represented by four or more geriatric specific initiatives that are developed to elevate the level of geriatric care, implemented by nurses and physicians who have achieved certification in geriatric emergency care.
About Memorial Hospital Pembroke: Part of Memorial Healthcare System, Memorial Hospital Pembroke is a community-based hospital offering worldclass care through its Emergency Department, freestanding 24/7 Emergency Care Center, medical and surgical services, Memorial Weight-Loss Surgery Program, Comprehensive Wound Healing Center and Hyperbaric Oxygen Therapy, and among many other services.
Jonathan Hogan, MD, Medical Director, Cabaletta Bio & Adjunct Associate Professor of Medicine, Division of Nephrology, University of Pennsylvania;
Barbara Gillespie, MD, VP and Therapeutic Head of Nephrology, Fortrea & Adjunct Professor, Division of Nephrology and Hypertension, University of North Carolina School of Medicine;
Frederick Derosier, DO, Vice President and General Manager, Rare Disease, Advanced Therapies and Pediatrics Team (RAPT), Clinical Lead, Enterprise Cell and Gene Therapy, Fortrea;
Paulla Dennis, Senior Director, Rare Disease, Advanced Therapies and Paediatrics Team (RAPT), Fortrea.
Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Redaction: Learn how AI-powered tools can identify and remove personally identifiable information (PII) from clinical trial documents, ensuring compliance with regulations such as the general data protection regulation (GDPR). Explore the potential for automated redaction, reducing the burden on investigator sites and contract research organizations (CROs) while maintaining data integrity.
Data completeness and validation: Discover how AI can review site provided documents and resulting event dossiers, providing an assessment ensuring that all data necessary to adjudicate events and endpoints have been provided. This automated data quality enhancing process will make initial reviews more agile, reducing queries and delay risks.
Process analysis and optimization: Explore how AI can help to analyze adjudication processes by looking at meta-data about how long individual steps are taking in long, multi-constituency workflows. AI can help determine where there may be bottlenecks as well as which areas could benefit from further training or workload balancing.
Computer-aided adjudication and eligibility reviews: Discuss how future AI models different may help evaluators to focus on the right data to increase consistency and reduce the time it takes to reach consensus. Examine whether models could reproduce for adjudicators what AI-enhanced systems have achieved in medical imaging analysis.
Discover how AI and large language models are revolutionizing the industry, and learn how AG Mednet’s Judi platform, alongside the right CRO and academic research organization (ARO) development partners, can empower an organization to drive efficiency, compliance and success in clinical development.
Register for the live webinar taking place on Wednesday, October 4, 2023, at 11am EDT (3pm GMT/UK) featuring expert speakers Abraham Gutman, CEO and Founder, AG Mednet; Catherine Tyner, Executive Director, Adjudication Services, Fortrea; Kimberly J. Brown, RN; and Venugopal Menon, MD, Section Head of Clinical Cardiology, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, to discover how to unlock the potential of AI in clinical trial workflow management.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
But, how can we be sure that sensor readings — even when carefully validated, calibrated and monitored — reflect how patients are truly feeling and functioning? Take fatigue, for example: A sleep monitor may indicate that a patient has had a long sleep cycle. That same patient may provide subjective report the next morning stating they feel exhausted. Each of these datapoints offers important information, so how do we balance the two in the context of drug development?
How do sponsors ensure that wearable measurements are not just accurate but also meaningful to patients? What should be done when sensor and ePRO data contradict each other?
In this session, we’ll take the audience on the journey of digital data capture, from eCOA to wearables, and discuss key questions, including:
Tactics for successfully incorporating digital device data collection into your trial
How to reconcile point-in-time ePRO data with continuous device data
How to manage and monitor the vast quantities of data transmitted by sensors/wearables
When to consider novel endpoints
How to address concerns about data privacy and security
This webinar offers a unique opportunity to gain critical insights into the selection and integration of fit-for-purpose digital instruments, as well as how to ensure accurate data collection in ways that maximize the signal-to-noise ratio and patient comfort.
Register for the live webinar taking place on Thursday, October 5, 2023, at 10am EDT (3pm BST/UK) that will feature expert speakers Florence Mowlem, PhD, Vice President of Science, ObvioHealth; Helen Shaw, PhD, Co-founder, Director, Head of Clinical Operations, VCTC; and Ryan Kennedy, Global Vice President of Product (Life Science Global Business Unit), Oracle.
ABOUT XTALKS Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Through December 1, 2023, college or college-affiliated swim teams will compete in the Swim Across America College Cup, a fundraising competition among collegiate teams in the U.S. Teams can participate by registering for one of Swim Across America’s open water charity swims, joining or starting a pool swim, or participating virtually through the SAA My Way program. Participants must be affiliated with a U.S-based college or university to be eligible to compete in the College Cup. Teams may consist of current college students, alumni or a mix of both, and can be as small as one person.
To date, more than 30 teams consisting of 1,000 participants are currently enrolled in the College Cup’s inaugural year. As the college swim season peaks, Swim Across America expects those numbers to increase and encourages teams, clubs and alumni groups who want to join to do so at swimacrossamerica.org/collegecup.
“One of the exciting aspects of the Swim Across America College Cup program is that it offers a new way for alumni to stay engaged with their college swim teams,” noted John O’Neill, head coach of the Providence College men’s and women’s swimming and diving programs and a long-time participant in Swim Across America open water swims. “It allows them to lead the next generation of athletes in the swimming world and instill a philanthropic mindset.”
Fundraising by the College Cup teams will support cancer research and clinical trials in the community in which teams register to swim. If teams are participating in a national pool swim, funds support the Swim Across America pediatric cancer research fund. Swim Across America offers 24 open water swims across the country and hundreds of pool swims each year.
The College Cup brings several exciting partnerships to Swim Across America, including the College Swimming Coaches Association of America (CSCAA) and Vasa, a fitness and rehabilitation company focused on peak performance for swimmers, surfers and triathletes.
As part of their partnership, CSCAA will recognize the top individual College Cup fundraiser at their annual awards ceremony.
“We are thrilled to rejuvenate the partnership between Swim Across America and the CSCAA,” said Samantha Barany, executive director of CSCAA. “The philanthropic efforts of Swim Across America are impressive and impact nearly everyone in some way with the fight against cancer. The open water events hosted by Swim Across America are an excellent opportunity for our college teams and athletes to engage in charitable endeavors within a familiar and loved environment – the water. We will continue to find more ways to collaborate and I believe this is just the beginning!”
Vasa will award a Vasa Swim Ergometer to two participating teams. One will be awarded to the top College Cup fundraising team and the second will be awarded to a randomly selected team participating in the College Cup. All teams have the opportunity to win through their participation.
Swim Across America College Ambassadors
Swim Across America is also excited to announce another new college initiative, the Swim Across America College Ambassadors program. College Ambassadors will be the face of Swim Across America at their college or university and lead efforts to raise awareness of Swim Across America’s mission to fund cancer research, clinical trials and patient programs by hosting charity swims. College Ambassadors are passionate about Swim Across America and help engage their peers, promote the Swim Across America mission and brand, and encourage their local communities’ involvement.
Earlier this year, Swim Across America invited college students to apply for the Swim Across America College Ambassadors program. Applicants were asked to share why they are passionate about Swim Across America, highlight any previous leadership experience, and outline their aspirations for participating in the program. More than 30 applications were reviewed by a Swim Across America selection committee and 21 college students were selected to be College Ambassadors for 2023. Students selected represent colleges across the country, including University of South Florida, Roger Williams University and Northeastern University.
Beyond their role as ambassadors, these students also serve as team captains for teams participating in the College Cup or any Swim Across America event. To learn about the Swim Across America College Ambassador program, visit swimacrossamerica.org/ambassadors.
Swim Across America was founded in 1987 with its first open water event in Long Island Sound. Since that time, the nonprofit organization has raised more than $100 million to fight cancer. In its 36 years of making waves to fight cancer, more than 100,000 swimmers and 150 Olympians have swum the circumference of the earth three times, uniting a movement to fight cancer that has created a groundswell of support spanning all generations. Today, more than 24 communities hold open water swims and hundreds of charity pool swims each year, from Nantucket to under the Golden Gate Bridge, which support innovative cancer research, detection and patient programs.
Swim Across America’s funding of clinical trials for patients helped contribute to four FDA approved life-saving immunotherapy cancer treatments: Yervoy, Opdivo, Tecentriq and Keytruda. In June of last year, a clinical trial at Memorial Sloan Kettering was published in The New England Journal of Medicine that showed a 100 percent success rate in treating patients in a phase 2 clinical trial for advanced rectal cancer with dostarlimab, an immunotherapy treatment produced by GlaxoSmithKline. The clinical trial at Memorial Sloan Kettering was funded by early-stage grant funding from Swim Across America. More than 60 scientific grants are funded each year and there are now ten dedicated Swim Across America Labs at major institutions including: Children’s Healthcare of Atlanta, John Hopkins Medicine Atlanta, Rush University Medical Center Chicago, Baylor Scott & White Charles A. Sammons Cancer Center in Dallas, Memorial Sloan Kettering Cancer Center New York, Infusion Center at Nantucket Cottage Hospital, UCSF Benioff Children’s Hospital Oakland and San Francisco, the Seattle Cancer Care Alliance, The Swim Across America Pediatric Research Lab at Columbia University Medical Center New York, and The Swim Across America Laboratory at Meyer Cancer Center at Weill Cornell Medicine.
About Swim Across America
Swim Across America, Inc. (SAA) is dedicated to raising money and awareness for cancer research, prevention and treatment through swimming-related events. With the help of hundreds of volunteers nationwide and past and current Olympians, Swim Across America is helping find a cure for cancer through athleticism, community outreach and direct service. To learn more visitswimacrossamerica.org or follow on Facebook @SwimAcrossAmerica or on Instagram or Twitter @SAASwim.
About CSCAA
Founded in 1922, the CSCAA is the nation’s first professional coaching association for intercollegiate athletics. The CSCAA boasts more than 2,000 member coaches and assistant coaches, recognizes All-American swimmers and divers, NCAA record-breakers and Scholar All-America athletes and teams, as well as outstanding coaches and contributors, and helps oversee the welfare of collegiate swimming and diving. Learn more about CSCAA at cscaa.org.
About Vasa
Vasa empowers swimmers, surfers and triathletes to become stronger, better, faster in sports, fitness and injury rehab. Vasa offers specific equipment such as swim ergometers, trainers, sport benches and other accessories to provide athletes with safe, effective training methods. Founded by Rob Sleamaker, an acclaimed exercise physiologist and author, who has worked with Olympians, biathletes and triathletes as well as some of the world’s most respected swim coaches to reinvent their training practices. Learn more about Vasa at vasatrainer.com.
